Clinical trials: Sitosterolemia
Sitosterolemia
Sitosterolemia Metabolism
Ezetimibe has become the treatment choice for patients with sitosterolemia. Ezetimibe is an inhibitor of cholesterol absorption from the gastrointestinal tract.
- Trial name
- STAIR7002 (NCT01584206)
- Testing
- Ezetimibe
- Where
- Canada
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- University of Manitoba
Lipid Metabolism, Inborn Errors, Sitosterolemia
Genetic Study of Sitosterolemia
OBJECTIVES: I. Identify the genetic defect and fine map the gene that causes sitosterolemia.
- Trial name
- NCT00004481
- Testing
- genetic testing
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- National Center for Research Resources (NCRR)